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Aims Diastolic dysfunction (DD) is frequent in the general population; however, the assessment of diastolic function
remains challenging. We aimed to evaluate the impact of the recent 2016 American Society of Echocardiography
(ASE)/European Association of Cardiovascular Imaging (EACVI) recommendations in the prevalence and grades of
DD compared with the 2009 guidelines and the Canberra Study Criteria (CSC).
...................................................................................................................................................................................................
Methods
and results
Within a population-based cohort, a total of 1000 individuals, aged >_45 years, were evaluated retrospectively.
Patients with previously known cardiac disease or ejection fraction <50% were excluded. Diastolic function was
assessed by transthoracic echocardiography. DD prevalence and grades were determined according to the three
classifications. The mean age was 62.0 ± 10.5 years and 37% were men. The prevalence of DD was 1.4% (n= 14)
with the 2016 recommendations, 38.1% (n= 381) with the 2009 recommendations, and 30.4% (n= 304) using the
CSC. The concordance between the updated recommendations and the other two was poor (from k= 0.13 to
k= 0.18, P< 0.001). Regarding the categorization in DD grades, none of the 14 individuals with DD by the 2016
guidelines were assigned to Grade 1 DD, 64% were classified as Grade 2, 7% had Grade 3, and 29% had indetermi-
nate grade.
...................................................................................................................................................................................................
Conclusion The application of the new 2016 ASE/EACVI recommendations resulted in a much lower prevalence of DD. The
concordance between the classifications was poor. The updated algorithm seems to be able to diagnose only the
most advanced cases.
                                                                                                                                                                                                                   
Keywords diastole • echocardiography • diastolic dysfunction • heart failure
Introduction
Left ventricular (LV) diastolic dysfunction (DD) is frequent in the gen-
eral population1 and contributes to the development and progres-
sion to heart failure with preserved ejection fraction (HFpEF).2,3 DD
is an important predictor of incident heart failure4 and total
mortality.5 However, the assessment of diastolic function remains
challenging, because several parameters and different criteria have
been used for its evaluation. The majority of available cut-off values
and recommendations for diagnosing and grading DD were derived
from experienced international centres,1,6,7 and the heterogeneity
and ambiguity of the different definitions led to a significant variability
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in the reported prevalence and grading of DD.8 Recently, the 2016
American Society of Echocardiography (ASE)/European Association
of Cardiovascular Imaging (EACVI) recommendations have been
published.9 Acknowledging the complexity of the 2009 ASE/
European Association of Echocardiography (EAE) recommenda-
tions,7 this update aimed to simplify the diagnosis and classification of
DD in daily clinical practice, using the most feasible and reproducible
parameters of diastolic function and providing algorithms with hier-
archical organization. Our aim was to evaluate the impact of the 2016
ASE/EACVI recommendations in the prevalence and grades of DD in
the general population, comparing with the 2009 guidelines and the
Canberra Study Criteria (CSC).
Methods
Study population
The study population included participants from the EPIPorto cohort
study, which at baseline was representative of the adult population of
Porto (Portugal). Between 1999 and 2003, the EPIPorto population was
selected using random digit dialling, with households as sampling frame. In
each household, a random selection of one person aged 18 years or
more was made and refusals were not substituted within the same house-
hold. A total of 2485 individuals were recruited (proportion of participa-
tion 70%).10 From October 2006 to July 2008, participants aged 45 years
or more were evaluated with a cardiovascular clinical history, physical
examination, detailed anthropometric parameters, fasting blood samples
and submitted to a comprehensive transthoracic echocardiography
(TTE). From the initial 2048 participants, 134 (6.5%) had died, 198 (9.7%)
refused to be re-evaluated, and 580 (28.3%) were lost to follow-up. For
this retrospective analysis, we excluded individuals with systolic dysfunc-
tion (ejection fraction <50%), previous myocardial infarction, percutane-
ous or surgical myocardial revascularization, more than mild valvular
heart disease, sinus tachycardia, atrial fibrillation or flutter, permanent
pacemaker, and complete left bundle branch block (136 excluded).
Written informed consent was obtained from all participants, and the
local ethics committee (‘Comissa~o de E´tica do Centro Hospitalar S. Joa~o,
EPE’) approved the study. The investigation conforms to the principles of
the 1975 Declaration of Helsinki.
Clinical variables definitions
Arterial hypertension was determined as a systolic blood pressure
>_140mmHg, a diastolic blood pressure >_90mmHg, or the use of antihy-
pertensive drugs. Obesity was defined as body mass index >_30 kg/m2.
Type 2 diabetes mellitus was determined by self-reported diagnosis, fast-
ing glucose level of at least 126 mg/dL, or the use of antidiabetic agents.
Dyslipidaemia was defined as total serum cholesterol >_220 mg/dL or the
use of lipid-lowering drugs. Metabolic syndrome was defined according
the American Heart Association updated National Cholesterol
Education Program Adult Treatment Panel III criteria. Symptomatic heart
failure was determined according to the definition by the American
College of Cardiology and American Heart Association.11 Exertional
dyspnoea, orthopnoea, nocturnal paroxysmal dyspnoea, evening lower
limb oedema (in the absence of chronic venous insufficiency), jugular
venous distension, and rales were considered symptomatic heart failure
when at least two of them were present.
Echocardiographic evaluation
TTE studies were performed using the same ultrasound system (Hewlett-
Packard Sonos 5500). Stored images were analysed offline by two
experienced cardiologists, blinded to clinical data. Chamber quantification
and function was assessed according the 2005 ASE/EAE recommen-
dations.12 Left atrial (LA) volume was measured at end-ventricular systole,
avoiding foreshortening of the atrium, using apical views and Simpson’s
rule. Volumes were indexed to body surface area. LV systolic function was
evaluated by determination of ejection fraction using the modified
Simpson’s rule from biplane using four and two-chamber views. Types of
LV hypertrophy were determined using LV mass index and relative wall
thickness, according to the most recent recommendations.13 Evaluation of
diastolic function was performed from TTE apical views, using recorded
velocities at end expiration, averaging over three consecutive cardiac
cycles. Mitral inflow velocities (E-wave and A-wave) and deceleration time
(DT) were measured at the tips of the mitral leaflets with pulsed-wave
Doppler. Lateral mitral annulus velocities (e0 and a0) were measured with
tissue Doppler imaging. The E/A ratio and the lateral E/e0 ratio were calcu-
lated accordingly. Tricuspid regurgitation (TR) peak velocity was deter-
mined using continuous-wave Doppler and simplified Bernoulli equation.
Classification of diastolic function
DD prevalence and grades were determined using three different classifica-
tions. The first classification was based on the 2009 ASE/EAE recommenda-
tions for the evaluation of LV diastolic function.7 This grading system
suggests starting with e0 velocities and indexed LA volume. After that, we
used E/A ratio, DT and lateral E/e0 cut-offs from the five suggested meas-
ures. At least two positive measures were needed to attribute a DD grade.
When it was not possible to grade DD due to discrepancies between dif-
ferent parameters, they were considered as indeterminate. The second
grading system was based on the CSC.6 This classification categorizes indi-
viduals based on mitral inflow (E/A and DT), pulmonary venous inflow, and
lateral E/e0 ratio. In case of doubt or missing value, patients were classified
as indeterminate. Finally, the third classification used the 2016 ASE/EACVI
recommendations for the evaluation of diastolic function.9 The first step
relies on the diagnosis of DD in patients with normal LV ejection fraction.
Using E/e0 ratio, lateral e0 velocity, TR velocity, and indexed LA volume, the
patients were classified as having normal diastolic function, DD, or indeter-
minate. These guidelines recommend using the average E/e0 ratio, but it is
recognized that some laboratories, similar to ours, only measure lateral or
septal e0. Therefore, we used the recommended cut-off for lateral E/e0 ratio
(>13). The second step consisted in applying the 2016 DD grading algo-
rithm to individuals previously classified as having DD in Step 1. The grading
system starts with the evaluation of E/A ratio and E-wave velocity, and
then, using lateral E/e0 , TR, and indexed LA volume, the patients were
graded. DD classification was performed by two independent investigators
blinded to patient characteristics.
Statistical analysis
Continuous variables are presented as mean ± standard deviation (SD),
and categorical variables are presented as absolute numbers and percen-
tages. Comparisons between normal, DD, and indeterminate individuals
were performed using one-way analysis of variance or Kruskal–Wallis
test for continuous variables and the v2 test or exact Fisher’s test for cat-
egorical variables, as appropriate. The concordance between the three
classifications was determined using kappa coefficients and proportion of
agreement. The concordance was defined as poor (0–0.20), fair (0.21–
0.40), moderate (0.41–0.60), good (0.61–0.80), and optimal (0.81–1).14
The reclassification percentage was determined as: 100 - proportion of
agreement. A P-value of <0.05 was considered for statistical significance.
All tests were two tailed. Data analysis was performed using SPSS version
23 (SPSS Inc., Chicago, IL, USA).
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In this study, 1000 individuals were included, 37% were men, with a
mean age of 62 ± 10.5 years, as detailed in Table 1. The feasibility of
the four echocardiographic parameters recommended by the 2016
guidelines for the diagnosis of DD was very high (98.4–100%). We
assessed the prevalence of these diastolic parameters in our popula-
tion: LA volume index >_34 ml/m2 was present in 26%, TR velocity
>2.8 m/s in 1.2%, lateral e0 velocity <10 cm/s in 44.6%, and lateral E/e0
>13 in 4.2%. The prevalence of DD was 1.4% (n= 14) with the 2016
recommendations, 38.1% (n= 381) with the 2009 recommendations,
and 30.4% (n= 304) using the CSC, as shown in Figure 1. Table 2
presents the comparison of the patient characteristics between the
different groups (normal, DD, and indeterminate) using the 2009 and
the 2016 guidelines. With the 2016 recommendations, we observed
significant differences in several clinical and echocardiographic param-
eters between groups. On the contrary, using the 2009 guidelines,
we did not observe statistical differences between the groups,
regarding gender, obesity, LA and LV volume indexes, and ejection
fraction. The concordance between the 2016 and 2009 recommen-
dations was poor (k= 0.18, P< 0.001), with a reclassification rate of
41%, as showed in Figure 2. From the 381 patients classified as having
DD using the 2009 recommendations, 250 (66%) patients were
reclassified as normal patients and 31% (120/381) as indeterminate
cases. There was agreement in 11 of the 14 individuals labelled as DD
cases with the 2016 recommendations and the previous guidelines,
as detailed in Table 3. Of the 15% indeterminate cases by the newer
recommendations, 79% (120/152) were classified as having DD by
the 2009 recommendations. Comparing the 2016 recommendations
with the CSC, there was also a poor agreement in the prevalence of
DD (k= 0.13, P< 0.001), with a reclassification rate of 41%. The appli-
cation of the 2016 guidelines resulted in reclassification of 67% (205/
304) of DD patients as normal patients and of 70% (71/101) of inde-
terminate patients as normal individuals, as detailed in Table 4.
Furthermore, 60% (91/152) of the indeterminate cases by the 2016
recommendations were classified as having DD by the CSC. Finally,
between the 2009 recommendations and the CSC, we found a fair
.................................................................................................
Table 1 Clinical and echocardiographic characteris-
tics of the study sample
All patients
(n5 1000)
Age (years) 62.0 ± 10.5
Gender (male) 370 (37)
Body mass index (kg/m2) 27.5 ± 4.6
Arterial hypertension 702 (70.4)
Obesity 253 (25.3)
Dyslipidaemia 548 (54.8)
Type 2 diabetes mellitus 114 (11.4)
Metabolic syndrome 406 (41.2)
Heart failure 46 (4.6)
NYHA Class I/II (%) 30/50
NYHA Class III (%) 20
Medication
Inhibitors of the renin–angiotensin system 232 (23.2)
Calcium channel blocker 70 (7)
Diuretics 111 (11.1)
Ejection fraction (%) 60.7 ± 6.0
Left atrial volume index (mL/m2) 28.8 ± 9.9
Left ventricular end-systolic volume index (mL/m2) 26.7 ± 8.9
Left ventricular end-diastolic volume index (mL/m2) 66.0 ± 16.0
Left ventricular mass index (g/m2) 79.3 ± 19.0
Eccentric left ventricular hypertrophy 72 (7.2)
Concentric left ventricular hypertrophy 24 (2.4)
Left ventricular concentric remodelling 39 (3.9)
Tricuspid regurgitation peak velocity (cm/s) 2.3 ± 0.3
E/A ratio 0.97 ± 0.32
Deceleration time (ms) 237 ± 54
Isovolumetric relaxation time (ms) 91.6 ± 15.8
Lateral e0 velocity (cm/s) 10.5 ± 3.2
Lateral E/e0 7.4 ± 2.7
Data are represented as mean ± standard deviation for continuous variables and
n (%) for categorical variables.
NYHA, New York Heart Association.
Figure 1 Prevalence of diastolic dysfunction, according to each classification.
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agreement (k= 0.35, P< 0.001). The categorization in DD grades
according to the different algorithms is shown in Figure 3. Using the
2016 guidelines, none of the 14 subjects with DD were assigned as
Grade 1 DD. Most of the individuals (64%) were classified as Grade 2
DD, 7% as Grade 3 DD, and 29% as indeterminate grade.
Discussion
Prevalence of diastolic dysfunction
In this population, we found that the application of the 2016 diastolic
function recommendations resulted in a significantly lower preva-
lence of DD (1.4%), when compared with the estimation by the 2009
guidelines (38.1%) and the CSC (30.4%). Furthermore, the concord-
ance rates were poor, with reclassification rates exceeding 40%. The
use of the 2016 classification also resulted in a significant increase in
the number of indeterminate cases (about 15%). We observed that
between 60% and 80% of those indeterminate cases were considered
to have DD by the previous guidelines and the CSC. Therefore, con-
sidering these data and the clinical and echocardiographic characteris-
tics of these individuals, it is plausible that these individuals could also
have a milder degree of DD, although not fulfilling yet all the
Figure 2 Concordance in diastolic dysfunction prevalence
according to the 2009 ASE/EAE recommendations and the 2016
ASE/EACVI recommendations. Number of normal, diastolic dys-
function, and indeterminate cases as classified by the 2009 recom-
mendations are represented on the left. Patients reclassified by the
2016 updated guidelines are reported on the right.
.................................................................................. ..................................................................................
....................................................................................................................................................................................................................
Table 2 Comparison of clinical and echocardiographic characteristics between patients with normal diastolic func-
tion, diastolic dysfunction, and indeterminate cases, using the 2016 and 2009 recommendations
2016 Recommendations 2009 Recommendations
Normal
(n5 834)
DD
(n5 14)
Indeterminate
(n5 152)
P-value Normal
(n5 554)
DD
(n5381)
Indeterminate
(n565)
P-value
Age (years) 60.4 ± 10.1 72.2 ± 11.6 69.7 ± 8.5 <0.001 57.6 ± 9.4 67.3 ± 9.3 68.1 ± 9.1 <0.001
Male gender 322 (38.6) 6 (42.9) 42 (27.6) 0.031 208 (37.5) 140 (36.7) 22 (33.8) 0.826
Arterial hypertension 550 (66.2) 14 (100) 137 (90.7) <0.001 325 (58.8) 321 (84.9) 55 (84.6) <0.001
Dyslipidaemia 444 (53.2) 6 (42.9) 98 (64.5) 0.023 276 (49.8) 234 (61.4) 38 (58.5) 0.002
Type 2 diabetes 81 (9.7) 5 (35.7) 28 (18.4) <0.001 44 (7.9) 55 (14.4) 15 (23.1) <0.001
Obesity 198 (23.7) 4 (28.6) 51 (33.6) 0.036 133 (24) 98 (25.7) 22 (33.8) 0.217
Metabolic syndrome 309 (37.7) 7 (50.0) 90 (59.2) <0.001 168 (30.7) 201 (53.9) 37 (56.9) <0.001
Body mass index (kg/m2) 27.3 ± 4.7 28.1 ± 5.0 28.3 ± 4.1 0.032 26.9 ± 4.9 28.1 ± 4.2 28.8 ± 4.0 <0.001
Heart failure 27 (3.2) 2 (14.3) 17 (11.2) <0.001 16 (2.9) 27 (7.1) 3 (4.6) 0.009
Ejection fraction (%) 60.7 ± 6.2 58.9 ± 6.9 59.1 ± 5.3 0.008 60.8 ± 5.9 60.2 ± 6.5 59.0 ± 5.6 0.060
LA volume index (mL/m2) 26.8 ± 8.4 44.1 ± 10.9 38.2 ± 10.5 <0.001 28.3 ± 9.3 29.6 ± 10.6 28.0 ± 10.3 0.139
LVESV (mL/m2) 25.9 ± 8.6 32.7 ± 11.7 30.3 ± 9.0 <0.001 26.4 ± 8.7 27.0 ± 9.2 27.6 ± 8.8 0.445
LVEDV (mL/m2) 64.8 ± 15.5 77.1 ± 18.1 71.7 ± 17.0 <0.001 65.9 ± 15.7 66.4 ± 16.8 64.7 ± 14.5 0.696
LV mass index (g/m2) 77.0 ± 17.2 107.0 ± 34.0 89.3 ± 21.0 <0.001 74.1 ± 16.2 86.0 ± 20.7 84.9 ± 16.6 <0.001
LV hypertrophy 57 (6.9) 4 (28.6) 35 (23.2) <0.001 20 (3.6) 67 (17.7) 9 (13.8) <0.001
LV concentric remodelling 33 (4) 1 (7.1) 5 (3.3) 0.517 16 (2.9) 19 (5) 4 (6.2) 0.130
TR peak velocity (cm/s) 2.3 ± 0.3 2.7 ± 0.2 2.4 ± 0.3 <0.001 2.3 ± 0.3 2.4 ± 0.2 2.4 ± 0.3 0.006
E/A ratio 1.0 ± 0.3 1.1 ± 0.6 0.8 ± 0.4 <0.001 1.1 ± 0.3 0.8 ± 0.3 0.9 ± 0.2 <0.001
DT (ms) 231.7 ± 49.9 233.9 ± 54.1 267.7 ± 63.0 <0.001 222.5 ± 45.1 258.2 ± 58.0 239 ± 52.8 <0.001
IVRT (ms) 90.4 ± 15.4 94.4 ± 24.2 98.0 ± 15.6 <0.001 89.2 ± 14.8 95.8 ± 16.1 87.5 ± 18.1 <0.001
Lateral e0 velocity (cm/s) 11.1 ± 3.1 7.1 ± 1.7 7.5 ± 1.7 <0.001 12.8 ± 2.4 7.8 ± 1.4 7.3 ± 1.5 <0.001
Lateral E/e0 6.8 ± 2.0 13.0 ± 4.3 10.0 ± 3.5 <0.001 6.0 ± 1.5 8.7 ± 2.5 11.5 ± 3.6 <0.001
Data are represented as mean ± standard deviation for continuous variables and n (%) for categorical variables.
LVESV, left ventricular end-systolic volume; LVEDV, left ventricular end-diastolic volume; IVRT, isovolumetric relaxation time.
Impact of the 2016 ASE/EACVI diastole recommendations 383
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echocardiographic criteria recommended in the 2016 guidelines.
Other community-based studies reported prevalence of DD ranging
from 11.1% to 36%, although applying different definitions and diag-
nostic algorithms.1,6,15–17 The large difference in the prevalence of
DD between the 2016 recommendations and the other two classifi-
cations is striking and unexpected. A similar difference was also found
by Huttin et al.18 in a population-based study with 1485 individuals.
The authors reported a DD prevalence of only 1.3%, much
lower than the prevalence obtained when using previous algorithms.
One possible explanation for this difference might be related with
the inclusion of the TR peak velocity in the newer recommendations.
Pulmonary systolic hypertension has been used as a surrogate meas-
ure of clinically significant pulmonary venous hypertension in patients
with HFpEF,19 being associated with echocardiographic evidence of
advanced DD due to chronic pressure overload.20 Therefore, TR
velocity is a parameter that probably reflects more advanced and
severe DD. In our sample, we observed a TR velocity >2.8 m/s in
only 1.2%. Therefore, the observations of a significantly lower preva-
lence of DD, associated with the amount of indeterminate cases by
the 2016 guidelines that were considered DD cases by the other two
recommendations (60–80%) suggest that the newer algorithm and
the inclusion of the TR parameter might have resulted in lower sensi-
tivity and higher specificity to diagnose DD. Consistent with these
observations, Obokata et al.21 showed that the new algorithm was
specific but poorly sensitive, being able to identify only 34% of individ-
uals with invasively proven HFpEF. Recently, the Euro-Filling study22
reported a fair sensitivity to diagnose elevated LV filling pressures
with the 2016 recommendations in patients undergoing simultaneous
invasive LV end-diastolic pressure measurement. Additionally, they
concluded that the algorithm was suboptimal in patients with pre-
served ejection fraction. Also using an echocardiographic–catheter-
ization design, Andersen et al.23 validated the 2016 algorithm in a
population of 450 patients, revealing good accuracy for the diagnosis
of elevated filling pressures. However, the studied population was
very different from ours, since patients without cardiac diseases were
excluded and only the algorithm for known cardiac disease was used.
Categorization in diastolic dysfunction
grades
Regarding the categorization in DD grades, the majority of patients
with DD were classified as Grade II of DD (9/14) when applying the
......................................................................................
....................................................................................................................................................................................................................
Table 3 Reclassification table of diastolic dysfunction prevalence using the 2009 and 2016 recommendations
2009 Recommendations
Normal DD Indeterminate Total
2016 Recommendations Normal 551 250 33 834
DD 0 11 3 14
Indeterminate 3 120 29 152
Total 554 381 65 1000
......................................................................................
....................................................................................................................................................................................................................
Table 4 Reclassification table of diastolic dysfunction prevalence for the 2016 recommendations and Canberra study
criteria
Canberra study criteria
Normal DD Indeterminate Total
2016 Recommendations Normal 558 205 71 834
DD 2 8 4 14
Indeterminate 35 91 26 152
Total 595 304 101 1000
Figure 3 Diastolic dysfunction grades, according to each
classification.
384 J.G. Almeida et al.
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2016 grading algorithm, with only one as Grade III DD, and none was
classified as Grade I DD. Another important observation using the
new classification is the large proportion of indeterminate grade
cases (29%). According to the 2016 DD grading algorithm, we can
imply that the indeterminate individuals correspond to cases in which
only two of three measures could be assessed (E/e0, TR velocity, and
LA volume index) and those two measures were discordant. It is
known that the concordance of the various echocardiographic
diastolic measures is lower in patients with preserved ejection
fraction,24 such as our cohort. The 2016 recommendations do not
provide further guidance in cases of discordant measures to use addi-
tional parameters, except for the pulmonary vein S/D ratio in patients
with LV systolic dysfunction. The prevalence and grades of DD have
prognostic impact,25 with a progressive increased risk of mortality
with the progression of DD,26 even in patients with preserved LV
ejection fraction.27 Thus, the observed differences between the algo-
rithms might have important clinical relevance. The rationale of the
2016 algorithm was the need to overcome the ambiguities associated
of the 2009 guidelines, which provided many parameters without
suggesting a minimal number of measures or a hierarchical classifica-
tion, resulting in suboptimal agreement between observers.8
However, the updated recommendations possibly caused an over-
simplification of the grading process, at least in patients with pre-
served ejection fraction, leading to discordant measures and possibly
lower discriminatory capacity to detect and grade DD. The absence
of patients classified as Grade I DD is another concern, suggesting
again that the new algorithm might be able to detect only the most
advanced cases. Future prospective studies will need to evaluate
whether the differences in DD prevalence and grades with the 2016
recommendations will change the role of DD as a prognosis marker.
Limitations
There was no specific gold standard to diagnose DD, thus the diag-
nostic accuracy of the three different classifications could not be
established. We included only patients with preserved LV ejection
fraction; therefore, these observations cannot be extrapolated to
patients with reduced ejection fraction. We did not assess pulmonary
venous inflow pattern, a parameter that is included in the CSC and
2009 algorithms, but we do not expect this would significantly change
the reported results. E0 velocity was assessed only at the lateral side
of the mitral annuls, and cases of discordant medial and lateral e0
velocities could have been misdiagnosed. Also, since our population
had a high prevalence of arterial hypertension and because DD devel-
ops earlier and greatly at the septal wall in hypertensive cardi-
omyopathy,28 the assessment of E0 only at the lateral side might
have contributed to underestimation of DD true prevalence.
Nevertheless, the relative differences between algorithms is probably
not explained by this, since we used the provided cut-offs for the use
of lateral E0 velocity by the CSC and 2009 criteria.
Conclusions
The application of the new 2016 ASE/EACVI recommendations for
diastolic function assessment resulted in a much lower prevalence of
DD. The concordance between the different diagnostic algorithms
was poor, which significantly changed the prevalence and
categorization in DD grades. The updated classification might be able
to detect only the most advanced cases. The prognostic impact of
this criteria needs to be further investigated in future prospective
studies.
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